Information relating to the one of the most promising coronavirus vaccines has been “unlawfully accessed” following a hack on the European regulatory body that’s in the final stages of approving it, the firms jointly developing the vaccine said on Wednesday.
ARS TECHNICA
This story originally appeared on Ars Technica, a trusted source for technology news, tech policy analysis, reviews, and more. Ars is owned by WIRED's parent company, Condé Nast.
The European Medicines Agency based in Amsterdam first disclosed the breach. The statement said only that the EMA had been subject to a cyberattack and that it had begun a joint investigation along with law enforcement. The agency didn’t say when the hack happened or whether the attackers sought vaccine information, tried to infect the network with ransomware, or wanted to pursue some other purpose. An EMA spokesperson said in an email that “the Agency is fully functional and work continues.”
Around the same time on Wednesday, pharmaceutical company Pfizer and biotech company BioNTech, issued a joint release that said, “Today, we were informed by the European Medicines Agency (EMA) that the agency has been subject to a cyber attack and that some documents relating to the regulatory submission for Pfizer and BioNTech’s Covid-19 vaccine candidate, BNT162b2, which has been stored on an EMA server, had been unlawfully accessed.”
The companies said that neither of their systems were ..
Support the originator by clicking the read the rest link below.
